- Home
- TSHA vs SOR Comparison
TSHA vs SOR Comparison
Compare TSHA & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- SOR
- Stock Information
- Founded
- TSHA 2019
- SOR 1968
- Country
- TSHA United States
- SOR United States
- Employees
- TSHA N/A
- SOR N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- SOR Investment Managers
- Sector
- TSHA Health Care
- SOR Finance
- Exchange
- TSHA Nasdaq
- SOR Nasdaq
- Market Cap
- TSHA 356.7M
- SOR 348.7M
- IPO Year
- TSHA 2020
- SOR N/A
- Fundamental
- Price
- TSHA $1.38
- SOR $41.51
- Analyst Decision
- TSHA Strong Buy
- SOR
- Analyst Count
- TSHA 8
- SOR 0
- Target Price
- TSHA $6.63
- SOR N/A
- AVG Volume (30 Days)
- TSHA 1.6M
- SOR 16.2K
- Earning Date
- TSHA 05-13-2025
- SOR 01-01-0001
- Dividend Yield
- TSHA N/A
- SOR 7.24%
- EPS Growth
- TSHA N/A
- SOR N/A
- EPS
- TSHA N/A
- SOR 6.50
- Revenue
- TSHA $8,333,000.00
- SOR N/A
- Revenue This Year
- TSHA N/A
- SOR N/A
- Revenue Next Year
- TSHA N/A
- SOR N/A
- P/E Ratio
- TSHA N/A
- SOR $6.41
- Revenue Growth
- TSHA N/A
- SOR N/A
- 52 Week Low
- TSHA $1.17
- SOR $36.41
- 52 Week High
- TSHA $4.32
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- TSHA 34.93
- SOR 42.46
- Support Level
- TSHA $1.59
- SOR $41.27
- Resistance Level
- TSHA $1.87
- SOR $42.50
- Average True Range (ATR)
- TSHA 0.15
- SOR 0.84
- MACD
- TSHA -0.01
- SOR 0.02
- Stochastic Oscillator
- TSHA 24.36
- SOR 22.09
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.